No Effect of 50 Hz 2.45 mT Magnetic Field on the Potency of Cisplatin, Mitomycin C, and Methotrexate in S. cerevisiae

References

• Botstein D., Fink G. R. Yeast: and experimental organism for modern biology. Science 1988; 240: 1439–1443
   PubMed Web of Science ®Google Scholar
• Cos J., Bellmunt J., et al. Comparative study of sequential combinations of placlitaxel and methotrexate on a human bladder cell line. Cancer Invest. 2000; 18: 429–435
   PubMed Web of Science ®Google Scholar
• Florez, J., Armijo, J. A., Mediavilla, A. Farmacología Humana, 3rd ed. Masson, S.A., Barcelona 1997
   Google Scholar
• Friedl A. A., Kiechle M., et al. Radiation-induced chromosome aberrations in Saccharomyces cerevisiae: influence of DNA repair pathways. Genetics 1998; 148: 975–988
   PubMed Web of Science ®Google Scholar
• Hannan C. J., Liang Y., et al. In vitro cytotoxicity against human cancer cell lines during pulsed magnetic field exposure. Anticancer Res. 1994; 14: 1517–1520
   PubMed Web of Science ®Google Scholar
• Harland J. D., Liburdy R. P. Environmental magnetic fields inhibit the antiproliferative action of tamoxifen and melatonin in a human breast cancer cell line. Bioelectromagnetics 1997; 18: 555–562
   PubMed Web of Science ®Google Scholar
• Haveman J., Bergs J. W., et al. Effect of hyperthermia on uptake and cytotoxicity of cisplatin in cultured murine mammary carcinoma cells. Oncol. Rep. 2005; 14: 561–567
   PubMed Web of Science ®Google Scholar
• IARC (2002). Static and extremely low-frequency (ELF) electric and magnetic fields. In: International Agency for Research on Cancer, Ed. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Vol. 80. Lyon.
   Google Scholar
• Kusumoto T., Holden S. A., et al. Hyperthermia and platinum complexes: time between treatments and synergy in vitro and in vivo. Int. J. Hyperthermia 1995; 11: 575–586
   PubMed Web of Science ®Google Scholar
• Liang Y., Hannan C. J., et al. Enhanced potency of daunorubicin against multidrug resistant subline KB-Ch-8-5-11 by a pulsed magnetic field. Anticancer Res. 1997; 17: 2083–2088
   PubMed Web of Science ®Google Scholar
• Loberg L. I., Luther M. J., et al. 60 Hz magnetic fields do not enhance cell killing by genotoxic chemicals in Ataxia telangiectasia and normal lymphoblastoid cells. Radiat. Res. 2000; 153: 685–689
   PubMed Web of Science ®Google Scholar
• Miyagi N., Sato K., et al. Effects of PEMF on a murine osteosarcoma cell line: drug-resistant (P-glycoprotein-positive) and non-resistant cells. Bioelectromagnetics 2000; 21: 112–121
   PubMed Web of Science ®Google Scholar
• Novák J., Stras˜ák L., et al. Effects of low-frequency magnetic fields on the viability of yeast Saccharomyces cerevisiae. Bioelectrochemistry 2007; 70: 115–121
   PubMed Web of Science ®Google Scholar
• Ohno S., Siddik Z. H., et al. Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells. Cancer Chemother. Pharmacol. 1994; 34: 302–306
   PubMed Web of Science ®Google Scholar
• Ohtsubo T., Saito H., et al. In vitro effect of hyperthermia on chemoenhancement and uptake of cisplatin in human pharyngeal carcinoma KB cells. Chemotherapy 1997; 43: 43–50
   PubMed Web of Science ®Google Scholar
• Okonogi H., Nakagawa M., Tsuji Y. The effects of a 4.7 tesla static magnetic field on the frequency of micronucleated cells induced by mitomycin C. Tohoku J. Exp. Med. 1996; 180: 209–215
   PubMed Web of Science ®Google Scholar
• Omote Y. An experimental attempt to potentiate therapeutic effects of combined use of pulsing magnetic fields and antitumor agents. Nippon Geka Gakkai Zasshi 1988; 89: 1155–1166
   PubMedGoogle Scholar
• Petin V. G., Kim J. K., et al. Some general regularities of synergistic interaction of hyperthermia with various physical and chemical inactivating agents. Int. J. Hyperthermia 2002; 18: 40–49
   PubMed Web of Science ®Google Scholar
• Ruiz-Gómez M. J., de la Peña L., et al. Influence of 1 and 25 Hz, 1.5 mT magnetic fields on antitumor drug potency in a human adenocarcinoma cell line. Bioelectromagnetics 2002; 23: 578–585
   PubMed Web of Science ®Google Scholar
• Ruiz-Gómez M. J., Prieto-Barcia M. I., et al. Static and 50 Hz magnetic fields of 0.35 and 2.45 mT have no effect on the growth of Saccharomyces cerevisiae. Bioelectrochemistry 2004; 64: 151–155
   PubMed Web of Science ®Google Scholar
• Sabo J., Mirossay L., et al. Effects of static magnetic field on human leukemic cell line HL-60. Bioelectrochemistry 2002; 56: 227–231
   PubMed Web of Science ®Google Scholar
• Scarfi M. R., Bersani F., et al. Spontaneous and mitomycin-C-induced micronuclei in human lymphocytes exposed to extremely low frequency pulsed magnetic fields. Biochem. Biphys. Res. Commun. 1991; 176: 194–200
   PubMed Web of Science ®Google Scholar
• Siede W., Friedl A. A., et al. The Saccharomyces cerevisiae Ku autoantigen homologue affects radiosensitivity only in the absence of homologous recombination. Genetics 1996; 142: 91–102
   PubMed Web of Science ®Google Scholar
• Souviron Rodríguez A., Ruiz-Gómez M. J., et al. Multirresistencia a drogas (MDR) en Oncología. An. Med. Interna. 1997; 14: 145–153
   PubMedGoogle Scholar
• Stansell M. J., Winters W. D., et al. Increased antibiotic resistance of E. coli exposed to static magnetic fields. Bioelectromagnetics 2001; 22: 129–137
   PubMed Web of Science ®Google Scholar
• Tofani S., Barone D., et al. Static and ELF magnetic fields enhance the in vivo anti-tumor efficacy of cis-platin against lewis lung carcinoma, but not of cyclophosphamide against B16 melanotic melanoma. Pharmacol. Res. 2003; 48: 83–90
   PubMed Web of Science ®Google Scholar
• Umezu K., Sugawara N., et al. Genetic analysis of yeast RPA1 reveals its multiple functions in DNA metabolism. Genetics 1998; 148: 989–1005
   PubMed Web of Science ®Google Scholar